| pubmed-article:20880733 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0085415 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:20880733 | lifeskim:mentions | umls-concept:C1514756 | lld:lifeskim |
| pubmed-article:20880733 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:20880733 | pubmed:dateCreated | 2010-11-15 | lld:pubmed |
| pubmed-article:20880733 | pubmed:abstractText | The concurrent use of nevirapine-based antiretroviral therapy (ART) and rifampin-containing anti-tuberculosis regimens for the treatment of HIV and tuberculosis (TB) is common in resource-limited countries. Long-term outcomes of this concurrent treatment are unknown. | lld:pubmed |
| pubmed-article:20880733 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20880733 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20880733 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20880733 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:20880733 | pubmed:issn | 1878-3511 | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:Sungkanuparph... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:ManosuthiWeer... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:ThongyenSuped... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:ChimsuntornSu... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:TantanathipPr... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:EampokarapBoo... | lld:pubmed |
| pubmed-article:20880733 | pubmed:author | pubmed-author:NilkamhangSam... | lld:pubmed |
| pubmed-article:20880733 | pubmed:copyrightInfo | Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20880733 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20880733 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:20880733 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20880733 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20880733 | pubmed:pagination | e1013-7 | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:meshHeading | pubmed-meshheading:20880733... | lld:pubmed |
| pubmed-article:20880733 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20880733 | pubmed:articleTitle | Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study. | lld:pubmed |
| pubmed-article:20880733 | pubmed:affiliation | Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand. drweerawat@hotmail.com | lld:pubmed |
| pubmed-article:20880733 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20880733 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
